Alnylam Pharmaceuticals is a pioneering biopharmaceutical company that specializes in RNA interference (RNAi) therapeutics. As the leading RNAi therapeutics company, Alnylam is dedicated to translating breakthrough science into transformational medicines to help patients worldwide. The company has a robust RNAi therapeutics platform and focuses on areas including ATTR amyloidosis. Alnylam is committed to delivering innovative treatments that address significant unmet medical needs.
Beta · Sourced from candidate reports
Be the first to share your experience with Alnylam Pharmaceuticals.
Your reply helps other candidates know what to expect.
